AI Summary
This article discusses the use of hydrazide-based class I selective HDAC inhibitors to completely reverse chemoresistance in platinum-resistant solid cancer cells. The study demonstrates that these inhibitors can work synergistically to overcome resistance to chemotherapy. This research is significant as it offers potential new strategies for treating patients with platinum-resistant cancers.